Serving leading biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: October 19, 2017
| Title: | Biodegradable polymer composition |
| Abstract: | The invention is directed to a composition composed of a thermoplastic or thermosetting polymer which is capable of forming a biodegradable and/or bioerodible microporous, solid or gelatinous polymer matrix. The matrix is useful as an implant in animals for enhancing regeneration of cells and tissue, such as bone and nerve cells, or for delivery of biologically-active substances to tissue or organs. The composition is administered to an implant site as a liquid. The invention also includes a method of preventing and treating disorders and diseases, such as bone or nerve growth disorders, or of altering body functions such as birth control, using the compositions and implants of the invention. |
| Inventor(s): | Dunn; Richard L. (Fort Collins, CO), Tipton; Arthur J. (Fort Collins, CO), Southard; George L. (Fort Collins, CO), Rogers; Jack A. (Fort Collins, CO) |
| Assignee: | Atrix Laboratories, Inc. (Fort Collins, CO) |
| Application Number: | 08/249,630 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Use; |
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | 653498 | ► Subscribe | |||||||||||||
| Australia | 666676 | ► Subscribe | |||||||||||||
| Australia | 2605492 | ► Subscribe | |||||||||||||
| Australia | 6614294 | ► Subscribe | |||||||||||||
| Canada | 2063729 | ► Subscribe | |||||||||||||
| Canada | 2079831 | ► Subscribe | |||||||||||||
| Canada | 2117394 | ► Subscribe | |||||||||||||
| Germany | 69006216 | ► Subscribe | |||||||||||||
| Germany | 69224456 | ► Subscribe | |||||||||||||
| Germany | 69429801 | ► Subscribe | |||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,949 others who get our Drug Patent Expiration Alerts:
